Cargando…

Inadequate Evidence to Support Phase III Studies of Albumin in Severe Malaria

Detalles Bibliográficos
Autores principales:	Woodrow, Charles J, Planche, Timothy
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851727/ https://www.ncbi.nlm.nih.gov/pubmed/17290301 http://dx.doi.org/10.1371/journal.pctr.0020004

Ejemplares similares

Phase III Trial of Albumin in Malaria Still Lacks Scientific Justification
por: Woodrow, Charles J, et al.
Publicado: (2007)

Problematic Analysis and Inadequate Toxicity Data in Phase III Apatinib Trial in Gastric Cancer
por: Zhang, Sheng
Publicado: (2016)

Phase III Trials Required to Resolve Clinical Equipoise over Optimal Fluid Management in Children with Severe Malaria
por: Maitland, Kathryn, et al.
Publicado: (2007)

Reappraisal of the Efficacy of a Simplified Artesunate Regimen in Falciparum Malaria
por: Woodrow, Charles J., et al.
Publicado: (2012)

Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?
por: Woodrow, Charles J, et al.
Publicado: (2017)

False reassurance or inadequate drug levels?
por: Tirlangi, Praveen, et al.
Publicado: (2020)

Claiming “New” in What Might be an Inadequate Search
por: Acién, Maribel, et al.
Publicado: (2015)

Respiratory research funding is inadequate, inequitable, and a missed opportunity
por: Williams, Siân, et al.
Publicado: (2020)

Inadequate study designs for the evaluation of blood pressure monitoring devices and their potential misleading conclusions
por: Almeida, Tiago P., et al.
Publicado: (2023)

Artesunate Dosing in Severe Falciparum Malaria
por: Dondorp, Arjen M., et al.
Publicado: (2012)

Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate
por: Uña, Esther
Publicado: (2009)

Volume Status in Severe Malaria: No Evidence Provided for the Degree of Filling of the Intravascular Compartment
por: Maitland, Kathryn, et al.
Publicado: (2005)

Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study
por: Van Voorhees, A.S., et al.
Publicado: (2021)

The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials
por: Yosipovitch, Gil, et al.
Publicado: (2022)

The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
por: Watson, James A., et al.
Publicado: (2023)

Outcome measures of phase III anticancer drug trials in China
por: Guo, Lanwei, et al.
Publicado: (2023)

Immunotherapy in patients with metastatic castration-resistant prostate cancer: a meta-analysis of data from 7 phase III studies and 3 phase II studies
por: Zhang, Anqiang, et al.
Publicado: (2022)

Authors' Reply
por: Krishna, Sanjeev, et al.
Publicado: (2005)

Prostate cancer and hypofractionation: reflections on recent randomised phase III clinical trial results
por: Dearnaley, David, et al.
Publicado: (2017)

Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care
por: Nazha, Aziz, et al.
Publicado: (2017)

Inadequate methods undermine a study of malaria, deforestation and trade
por: Kuschnig, Nikolas
Publicado: (2021)

High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19
por: Demoule, Alexandre, et al.
Publicado: (2020)

Coherence of evidence from systematic reviews as a basis for evidence strength - a case study in support of an epistemological proposition
por: Mickenautsch, Steffen
Publicado: (2012)

Tolerability of Saxagliptin in Patients with Inadequately Controlled Type 2 Diabetes: Results from 6 Phase III Studies
por: Davidson, Jaime A.
Publicado: (2014)

Congenital Malaria
por: Chinal, J.
Publicado: (1941)

Malaria in Bombay
por: Nerurker, J. S.
Publicado: (1931)

The Extermination of Malaria
por: Cornwall, J. W.
Publicado: (1900)

Is Malaria Infectious?
por: Weatherly, A. J.
Publicado: (1898)

The Extirpation of Malaria
por: Tull-Walsh, J. H.
Publicado: (1899)

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
por: Sanvictores, Diozele Hazel M, et al.
Publicado: (2012)

Peracrina versus Malaria
por: Walker, J.
Publicado: (1925)

Guidelines should not pool evidence from uncomplicated and severe COVID-19
por: White, Nicholas J, et al.
Publicado: (2021)

The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?)
por: Maude, Richard J., et al.
Publicado: (2009)

The Efficacy of Quinine in Malaria
por: McDonald, J.
Publicado: (1919)

Malaria v. Scurvy
por: Buchanan, W. J.
Publicado: (1898)

What causes severe malaria and its complications in children? Lessons learned over the past 15 years
por: Conroy, Andrea L., et al.
Publicado: (2019)

Quinine Urea in Malaria
por: Chinal, J. E. L.
Publicado: (1927)

The Provocative Diagnosis of Malaria
por: Chinal, J. E. Leonard
Publicado: (1926)

Quinine-Urea in Malaria
por: Chinal, J. E. Leonard
Publicado: (1926)

Plasmochin in Malaria
por: Mallik, D. K. L. Basu
Publicado: (1927)

Cannot write session to /tmp/vufind_sessions/sess_07osbrstb02boqh2oa50red2km